Is Decibel Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: DBTX) stock is to Buy DBTX stock.
Out of 2 analysts, 0 (0%) are recommending DBTX as a Strong Buy, 1 (50%) are recommending DBTX as a Buy, 1 (50%) are recommending DBTX as a Hold, 0 (0%) are recommending DBTX as a Sell, and 0 (0%) are recommending DBTX as a Strong Sell.
What is DBTX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: DBTX) forecast ROE is N/A, which is considered weak.
What is DBTX's Price Target?
According to 2 Wall Street analysts that have issued a 1 year DBTX price target, the average DBTX price target is $12.50, with the highest DBTX stock price forecast at $23.00 and the lowest DBTX stock price forecast at $2.00.
On average, Wall Street analysts predict that Decibel Therapeutics's share price could reach $12.50 by May 12, 2024. The average Decibel Therapeutics stock price prediction forecasts a potential upside of 219.69% from the current DBTX share price of $3.91.
What is DBTX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: DBTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.